What are the alternatives to oxymorphone (OxyContin) for managing constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternatives to OxyContin for Managing Constipation

For opioid-induced constipation, the most effective alternatives include traditional laxatives as first-line treatment, followed by peripherally acting μ-opioid receptor antagonists (PAMORAs) like methylnaltrexone or naloxegol for refractory cases. 1

First-Line Treatment Options

  • Begin with lifestyle modifications including increased fluid intake, regular physical activity, and toileting as soon as possible in response to the urge to defecate 1
  • Add a stimulant laxative such as bisacodyl (10-15 mg, 2-3 times daily) with a goal of one non-forced bowel movement every 1-2 days 1, 2
  • Consider adding osmotic laxatives if constipation persists:
    • Polyethylene glycol (PEG) produces a bowel movement within 1-3 days 3, 1
    • Lactulose or magnesium citrate can be effective alternatives 1, 4
  • Stool softeners like docusate sodium may be added, generally producing a bowel movement within 12-72 hours 5, 4

Second-Line Treatment Options

  • For persistent constipation, consider rectal interventions such as:
    • Glycerin suppositories for impaction 1
    • Rectal bisacodyl once daily 1, 6
  • If gastroparesis is suspected, add a prokinetic agent like metoclopramide 1, 2

Third-Line Treatment Options (For Refractory OIC)

  • Peripherally acting μ-opioid receptor antagonists (PAMORAs) are specifically designed to target the underlying mechanism of opioid-induced constipation while preserving pain control 1, 7, 8:
    • Methylnaltrexone 0.15 mg/kg subcutaneously every other day (no more than once daily) 1, 2
    • Naloxegol for patients with chronic non-cancer pain 1, 2
  • Secretagogues may be considered:
    • Lubiprostone activates chloride channels to enhance intestinal fluid secretion 1, 7
    • Linaclotide is a guanylate cyclase-C receptor agonist effective for chronic constipation 1, 7

Alternative Strategies

  • Consider opioid rotation to less constipating opioids (e.g., transdermal fentanyl causes less constipation than oral morphine) 1, 2
  • For severe cases, combination therapy may be necessary (e.g., lubiprostone with methylnaltrexone) 1, 7
  • Erythromycin or azithromycin may help with small bowel dysmotility in some cases 1

Important Considerations

  • Always rule out impaction, obstruction, and other treatable causes of constipation (hypercalcemia, hypokalemia, hypothyroidism, diabetes mellitus) before initiating treatment 1, 2
  • PAMORAs should not be used in patients with postoperative ileus or mechanical bowel obstruction 1, 7
  • Monitor for diarrhea with secretagogues, which can lead to dehydration 7
  • Increase fiber intake slowly over several weeks to minimize adverse effects like bloating 4, 9

Following this algorithmic approach will help manage constipation effectively while maintaining pain control with opioids, improving patient quality of life and reducing morbidity associated with untreated constipation.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid-Induced Constipation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Constipation in Older Adults.

American family physician, 2015

Guideline

Constipation Treatment Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Opioid-induced constipation.

Scandinavian journal of gastroenterology, 2015

Research

Medical management of constipation.

Clinics in colon and rectal surgery, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.